Mirati Therapeutics Inc.

NASDAQ: MRTX · Real-Time Price · USD
58.70
-0.10 (-0.17%)
At close: Jan 22, 2024, 10:00 PM

Mirati Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
PE Ratio
-3.44 -13.08
PEG Ratio
-0.2 -0.32
PS Ratio
204.88 105.57
PB Ratio
2.56 5.45
P/FCF Ratio
-4.43 -19.09
P/OCF Ratio
-4.47 -19.57
OCF/S Ratio
-45.88 -5.39
Debt / Equity Ratio
0.05 0.03
Quick Ratio
6.94 10.51
Current Ratio
6.96 10.50
Asset Turnover
0.01 0.05
Interest Coverage
n/a n/a
Return on Equity
-0.74 -0.42
Return on Assets
-0.62 -0.37
Return on Invested Capital
-0.72 -0.4
Dividend Yield
n/a n/a
Payout Ratio
n/a n/a
Gross Profit Margin
0.95 -6.05
Net Profit Margin
-59.57 -8.07
Pretax Profit Margin
-59.53 -8.02
Operating Profit Margin
-61.08 -7.95
FCF Margin
n/a n/a
EBITDA Margin
-60.84 -7.93